▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
April 16, 2024

Bio

ATGen partners with Sweden’s CellMark to sell cancer diagnosis kit in Europe

  • PUBLISHED :September 21, 2016 - 15:50
  • UPDATED :September 21, 2016 - 15:50
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[THE INVESTOR] ATGen announced on Sept. 21 that it has struck a strategic partnership with Swedish distributor CellMark to expand in the European market.

Through the international marketing network of its partner, ATGen will roll out its NK Vue Kit, which helps diagnosis of cancer and autoimmune diseases by gauging the activity of NK cells, a type of a white blood cell that composes innate immune system, with a small amount of blood.

CellMark was established in 1984 in Sweden and has grown to operate in 30 countries with 70 offices, and in a range of businesses from bio and health care to chemicals and metals.

By Hwang You-mee (glamazon@heraldcorp.com)

EDITOR'S PICKS